Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001064163 | SCV001229045 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001064163 | SCV004137098 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | LRP5: BP4 |
Ambry Genetics | RCV004030526 | SCV004899343 | uncertain significance | Inborn genetic diseases | 2023-10-27 | criteria provided, single submitter | clinical testing | The c.2724C>G (p.H908Q) alteration is located in exon 12 (coding exon 12) of the LRP5 gene. This alteration results from a C to G substitution at nucleotide position 2724, causing the histidine (H) at amino acid position 908 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Gastroenterology and Hepatology, |
RCV001844850 | SCV001877024 | likely benign | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research |